Gallstone disease and nonalcoholic fatty liver disease in patients with type 2 diabetes: a cross-sectional study

被引:8
|
作者
Lu, Ye [1 ]
Hu, Lili [2 ]
Song, Jing [1 ]
Wan, Jing [1 ]
Chen, Haibing [3 ]
Yin, Jun [1 ,2 ]
机构
[1] Shanghai Eighth Peoples Hosp, Dept Endocrinol & Metab, Shanghai 200235, Peoples R China
[2] Shanghai Jiao Tong Univ Affiliated Peoples Hosp 6, Shanghai Clin Ctr Metab Dis, Dept Endocrinol & Metab,Shanghai Diabet Inst, Shanghai Key Lab Diabet Mellitus, Shanghai 200233, Peoples R China
[3] Tongji Univ, Shanghai Peoples Hosp 10, Dept Endocrinol & Metab, Shanghai 200072, Peoples R China
基金
中国国家自然科学基金;
关键词
Type 2 diabetes mellitus; Gallstone disease; Cholecystectomy; Nonalcoholic fatty liver disease; CHOLESTEROL GALLSTONES; INSULIN-RESISTANCE; CHOLECYSTECTOMY; RISK; PREVALENCE; MANAGEMENT;
D O I
10.1186/s12902-021-00899-z
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Nonalcoholic fatty liver disease (NAFLD) and gallstone disease (GSD) often coexist in the general population owing to shared risk factors. This study explored the relationship between NAFLD and GSD in patients with type 2 diabetes. Methods We conducted a retrospective cross-sectional analysis of 4325 patients with type 2 diabetes. GSD and NAFLD were confirmed using ultrasonography. GSD was defined as either asymptomatic gallstones or previous cholecystectomy, and each was analyzed separately. Result There was no significant difference in the prevalence of GSD between patients with and without NAFLD (23.8% vs. 21.2%, P = 0.15). After case-control matching (1:1) of baseline data such as age, sex, duration of diabetes, and HbA1c between patients with and without NAFLD, there was still no significant difference in the prevalence of GSD (25.5% vs. 23.6%, P = 0.15). The prevalence of NAFLD in patients with asymptomatic gallstones was lower than that of patients without GSD (38.6% vs. 47.3%, P < 0.001), whereas the prevalence in those who had undergone cholecystectomy was much higher (61.2% vs. 47.3%, P < 0.001). The ratio of cholecystectomy to asymptomatic gallstone in patients with or without NAFLD was 1.97 and 0.79, respectively. The rate of cholecystectomy was higher in the patients with NAFLD than in those without NAFLD (15.8% vs. 9.3%, P < 0.001), consistent with the result after case-control matching (17.3% vs. 11.2%, P < 0.001). Multivariate logistic regression analysis, after adjusting for numerous potential confounding factors, revealed that GSD (OR = 1.241, 95%CI: 1.036-1.488, P = 0.002) and cholecystectomy (OR = 1.946, 95%CI: 1.546-2.445, P < 0.001) were both strongly associated with NAFLD. However, asymptomatic gallstone (OR = 0.663, 95%CI: 0.513-0.856, P = 0.002) seemed to be negatively correlated with NAFLD. Conclusions The prevalence of GSD was similar in patients with type 2 diabetes with and without NAFLD. The higher proportion of cholecystectomy and lower proportion of asymptomatic gallstones in patients with NAFLD suggests that NAFLD may increase the risk of complications of GSD.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] Role of micronutrients in staging of nonalcoholic fatty liver disease: A retrospective cross-sectional study
    Bertol, Franciele Sabadin
    Araujo, Bruna
    Jorge, Brunno Brochado
    Rinaldi, Natalino
    De Carli, Luiz Alberto
    Tovo, Cristiane Valle
    [J]. WORLD JOURNAL OF GASTROINTESTINAL SURGERY, 2020, 12 (06):
  • [22] Pharmacotherapy of type 2 diabetes in patients with chronic liver disease: focus on nonalcoholic fatty liver disease
    Raschi, Emanuel
    Mazzotti, Arianna
    Poluzzi, Elisabetta
    De Ponti, Fabrizio
    Marchesini, Giulio
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2018, 19 (17) : 1903 - 1914
  • [23] Noninvasive assessment of liver disease severity in patients with nonalcoholic fatty liver disease and type 2 diabetes
    Pennisi, G.
    Enea, M.
    Falco, V.
    Aithal, G. P.
    Palaniyappan, N.
    Yilmaz, Y.
    Boursier, J.
    Cassinotto, C.
    De Ledinghen, V.
    Chan, W. K.
    Mahadeva, S.
    Eddowes, P.
    Newsome, P.
    Karlas, T.
    Wiegand, J.
    Wong, V. Wai-Sun
    Schattenberg, J. M.
    Labenz, C.
    Kim, W.
    Lee, M. S.
    Lupsor-Platon, M.
    Cobbold, J. F. L.
    Fan, J.
    Shen, F.
    Staufer, K.
    Trauner, M.
    Stauber, R.
    Nakajima, A.
    Yoneda, M.
    Bugianesi, E.
    Younes, R.
    Gaia, S.
    Zheng, M.
    Camma, C.
    Anstee, Q. M.
    Mozes, F. E.
    Pavlides, M.
    Petta, S.
    [J]. DIGESTIVE AND LIVER DISEASE, 2023, 55 : S12 - S13
  • [24] Reliability and validity of the Chinese version of chronic liver disease questionnaire-nonalcoholic fatty liver disease in patients with nonalcoholic fatty liver disease: a multicenter cross-sectional survey in China
    Rui Huang
    Jian-Gao Fan
    Jun-Ping Shi
    Yi-Min Mao
    Bing-Yuan Wang
    Jing-Min Zhao
    Lun-Gen Lu
    Bi-Hui Zhong
    Zheng-Sheng Zou
    You-Qing Xu
    Yi-Nong Ye
    Long-Gen Liu
    Lian-Jie Lin
    Hui-Ying Rao
    Lai Wei
    [J]. Quality of Life Research, 2023, 32 : 915 - 922
  • [25] Nonalcoholic Fatty Liver Disease and Endothelial Dysfunction in Patients With Type 2 Diabetes
    Shin, Jang Yel
    Lim, Jung Soo
    Lee, Mi Young
    Chung, Choon Hee
    [J]. DIABETES, 2013, 62 : A119 - A119
  • [26] Dapagliflozin Therapy in Type 2 Diabetes Patients with nonalcoholic Fatty Liver Disease
    Kahl, S.
    [J]. DIABETOLOGE, 2018, 14 (07): : 506 - 508
  • [27] Reliability and validity of the Chinese version of chronic liver disease questionnaire-nonalcoholic fatty liver disease in patients with nonalcoholic fatty liver disease: a multicenter cross-sectional survey in China
    Huang, Rui
    Fan, Jian-Gao
    Shi, Jun-Ping
    Mao, Yi-Min
    Wang, Bing-Yuan
    Zhao, Jing-Min
    Lu, Lun-Gen
    Zhong, Bi-Hui
    Zou, Zheng-Sheng
    Xu, You-Qing
    Ye, Yi-Nong
    Liu, Long-Gen
    Lin, Lian-Jie
    Rao, Hui-Ying
    Wei, Lai
    [J]. QUALITY OF LIFE RESEARCH, 2023, 32 (03) : 915 - 922
  • [28] Nonalcoholic fatty liver disease in type 2 diabetes mellitus
    Cusi, Kenneth
    [J]. CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY, 2009, 16 (02) : 141 - 149
  • [29] Association between Nonalcoholic Fatty Liver and Gensini Score in Patients with Coronary Heart Disease: A Cross-Sectional Study
    Wang, Ping
    Qiang, Hua
    Song, Yan
    Dang, Ying
    Luan, Hui
    Cao, Lifei
    Cui, Qing
    Tian, Gang
    [J]. CARDIOLOGY, 2019, 144 (3-4) : 90 - 96
  • [30] Lifestyle predictors of obese and non-obese patients with nonalcoholic fatty liver disease: A cross-sectional study
    Kwak, Joo Hee
    Jun, Dae Won
    Lee, Seung Min
    Cho, Yong Kyun
    Lee, Kang Nyeong
    Lee, Hang Lak
    Lee, Oh Young
    Choi, Ho Soon
    Yoon, Byung Chul
    [J]. CLINICAL NUTRITION, 2018, 37 (05) : 1550 - 1557